Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

BACKGROUND: Early in the pandemic it was suggested that pre-existing use of non-steroidal anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with COVID-19. NSAIDs are an important analgesic, particularly in those with rheumatological disease, and are widely availab...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lancet Rheumatol
Main Authors: Drake, Thomas M, Fairfield, Cameron J, Pius, Riinu, Knight, Stephen R, Norman, Lisa, Girvan, Michelle, Hardwick, Hayley E, Docherty, Annemarie B, Thwaites, Ryan S, Openshaw, Peter J M, Baillie, J Kenneth, Harrison, Ewen M, Semple, Malcolm G
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier Ltd 2021
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8104907/
https://ncbi.nlm.nih.gov/pubmed/33997800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2665-9913(21)00104-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares